Anti-WDR83OS monoclonal antibody

Pre-made anti-WDR83OS monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to WDR83OS/WDR83OS products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2279-Ab-1/ GM-Tg-hg-IP2279-Ab-2Anti-Human WDR83OS monoclonal antibodyHuman
GM-Tg-rg-IP2279-Ab-1/ GM-Tg-rg-IP2279-Ab-2Anti-Rat WDR83OS monoclonal antibodyRat
GM-Tg-mg-IP2279-Ab-1/ GM-Tg-mg-IP2279-Ab-2Anti-Mouse WDR83OS monoclonal antibodyMouse
GM-Tg-cynog-IP2279-Ab-1/ GM-Tg-cynog-IP2279-Ab-2Anti-Cynomolgus/ Rhesus macaque WDR83OS monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2279-Ab-1/ GM-Tg-felg-IP2279-Ab-2Anti-Feline WDR83OS monoclonal antibodyFeline
GM-Tg-cang-IP2279-Ab-1/ GM-Tg-cang-IP2279-Ab-2Anti-Canine WDR83OS monoclonal antibodyCanine
GM-Tg-bovg-IP2279-Ab-1/ GM-Tg-bovg-IP2279-Ab-2Anti-Bovine WDR83OS monoclonal antibodyBovine
GM-Tg-equg-IP2279-Ab-1/ GM-Tg-equg-IP2279-Ab-2Anti-Equine WDR83OS monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2279-Ab-1/ GM-Tg-hg-IP2279-Ab-2; GM-Tg-rg-IP2279-Ab-1/ GM-Tg-rg-IP2279-Ab-2;
GM-Tg-mg-IP2279-Ab-1/ GM-Tg-mg-IP2279-Ab-2; GM-Tg-cynog-IP2279-Ab-1/ GM-Tg-cynog-IP2279-Ab-2;
GM-Tg-felg-IP2279-Ab-1/ GM-Tg-felg-IP2279-Ab-2; GM-Tg-cang-IP2279-Ab-1/ GM-Tg-cang-IP2279-Ab-2;
GM-Tg-bovg-IP2279-Ab-1/ GM-Tg-bovg-IP2279-Ab-2; GM-Tg-equg-IP2279-Ab-1/ GM-Tg-equg-IP2279-Ab-2
Products NameAnti-WDR83OS monoclonal antibody
Formatmab
Target NameWDR83OS
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-WDR83OS monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2279-Ag-1Recombinant multi-species ASTER/ WDR83OS/ C19orf56 protein


    Target information

    Target IDGM-IP2279
    Target NameWDR83OS
    Gene ID51398,414077,288925,716302,476703,101083404,508733,100064330
    Gene Symbol and SynonymsASTERIX,C19orf56,C7H19orf56,PAT-10,PAT10,PTD008,RGD1564058,WDR83OS
    Uniprot AccessionQ9Y284,A0A8I3NQW8,Q2M2T6
    Uniprot Entry NameASTER_HUMAN,-,ASTER_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000105583
    Target ClassificationN/A

    The target: WDR83OS, gene name: WDR83OS, also named as C19orf56, PTD008. Enables protein folding chaperone. Involved in protein insertion into ER membrane. Is integral component of endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.